Surveillance of vaccination coverage among adult populations - United States, 2014

MMWR Surveillance Summaries

Volumn 65, Issue 1, 2016, Pages 1-36

  Williams, Walter W ^a   Lu, Peng Jun ^a   O'Halloran, Alissa ^a   Kim, David K ^a   Grohskopf, Lisa A ^a   Pilishvili, Tamara ^a   Skoff, Tami H ^a   Nelson, Noele P ^b   Harpaz, Rafael ^a   Markowitz, Lauri E ^b   Rodriguez Lainz, Alfonso ^c   Bridges, Carolyn B ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ADULT; AGED; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; UNITED STATES; UTILIZATION; VACCINATION;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; UNITED STATES; VACCINATION; VACCINES;

EID: 84962440919     PISSN: 15460738     EISSN: 15458636     Source Type: Journal    
DOI: 10.15585/mmwr.ss6501a1     Document Type: Article

References (92)

1. CDC. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010;59:1057-62.
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333-40. http://dx.doi.org/10.1001/jama.292.11.1333.
3. Tomczyk S, Bennett NM, Stoecker C, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged =65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2014;63:822-5.
4. Yawn BP, Saddier P, Wollan PC, Sauver JLS, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341-9. http://dx.doi.org/10.4065/82.11.1341.
5. Williams WW, Lu P-J, O'Halloran A, et al. Vaccination coverage among adults, excluding influenza vaccination-United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:95-102.
6. Bridges CB, Hurley LP, Williams WW, Ramakrishnan A, Dean AK, Groom AV. Meeting the challenges of immunizing adults. Am J Prev Med 2015;49:S455-64.
7. Joon Lee T, Hayes S, Cummings DM, et al. Herpes zoster knowledge, prevalence, and vaccination rate by race. J Am Board Fam Med 2013;26:45-51. http://dx.doi.org/10.3122/jabfm.2013.01.120154.
8. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med 2008;121(Suppl 2):S28-35. http://dx.doi.org/10.1016/j.amjmed.2008.05.005.
9. Armstrong K, Berlin M, Schwartz JS, Propert K, Ubel PA. Barriers to influenza immunization in a low-income urban population. Am J Prev Med 2001;20:21-5. http://dx.doi.org/10.1016/S0749-3797(00)00263-4.
10. Winston CA, Wortley PM, Lees KA. Factors associated with vaccination of medicare beneficiaries in five U.S. communities: Results from the racial and ethnic adult disparities in immunization initiative survey, 2003. J Am Geriatr Soc 2006;54:303-10. http://dx.doi.org/10.1111/j.1532-5415.2005.00585.x.
11. National Foundation for Infectious Diseases. Call to action: adult vaccination saves lives. Bethesda, MD: National Foundation for Infectious Diseases; 2012. http://www.adultvaccination.org/resources/cta-adult.pdf.
12. Lu PJ, O'Halloran A, Williams WW. Impact of health insurance status on vaccination coverage among adult populations. Am J Prev Med 2015;48:647-61. http://dx.doi.org/10.1016/j.amepre.2014.12.008.
13. Stewart AM, Lindley MC, Chang KH, Cox MA. Vaccination benefits and cost-sharing policy for non-institutionalized adult Medicaid enrollees in the United States. Vaccine 2014;32:618-23. http://dx.doi.org/10.1016/j.vaccine.2013.11.050.
14. Hurley LP, Bridges CB, Harpaz R, et al. U.S. physicians' perspective of adult vaccine delivery. Ann Intern Med 2014;160:161-70. http://dx.doi.org/10.7326/M13-2332.
15. CDC. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years and older-United States, 2016. MMWR Morb Mortal Wkly Rep 2016. In press.
16. CDC. Flu vaccination coverage, United States, 2014-15 influenza season. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. http://www.cdc.gov/flu/fluvaxview/coverage-1415estimates.htm.
17. Black CL, Yue X, Ball SW, et al. Influenza vaccination coverage among health care personnel-United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep 2015;64:993-9.
18. Ding H, Black CL, Ball S, et al. Influenza vaccination among pregnant women-United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep 2015;64:1000-5.
19. CDC. Surveillance of influenza vaccination coverage-United States, 2007-08 through 2011-12 influenza seasons. MMWR Surveill Summ 2013;62(No. SS-4).
20. CDC. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR Recomm Rep 2013;62(No. RR-7).
21. Kostova D, Reed C, Finelli L, et al. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005-2011. PLoS One 2013;8:e66312. http://dx.doi.org/10.1371/journal.pone.0066312.
22. CDC. Estimated influenza illnesses and hospitalizations averted by influenza vaccination-United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2013;62:997-1000.
23. Reed C, Kim IK, Singleton JA, et al. Estimated influenza illnesses and hospitalizations averted by vaccination-United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep 2014;63:1151-4.
24. Community Preventive Services Task Force. The guide to community preventive services. Increasing appropriate vaccination: universally recommended vaccinations. Atlanta, GA: US Department of Health and Human Services, CDC; 2011. http://www.thecommunityguide.org/vaccines/index.html.
25. National Vaccine Advisory Committee. Recommendations from the National Vaccine Advisory committee: standards for adult immunization practice. Public Health Rep 2014;129:115-23.
26. CDC. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR MMWR Recomm Rep 2011;60(No. RR-7).
27. National Foundation for Infectious Diseases. Best practices poster. Bethesda, MD: National Foundation for Infectious Diseases; 2015. http://www.nfid.org/idinfo/influenza/poster.html.
28. Pavia AT. Mandate to protect patients from health care-associated influenza. Clin Infect Dis 2010;50:465-7. http://dx.doi.org/10.1086/650753.
29. Poland GA, Tosh P, Jacobson RM. Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine 2005;23:2251-5. http://dx.doi.org/10.1016/j.vaccine.2005.01.043.
30. Black CL, Yue X, Ball SW, et al. Influenza vaccination coverage among health care personnel-United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep 2014;63:805-11.
31. Tomczyk S, Bennett NM, Stoecker C, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged =65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2014;63:822-5.
32. CDC. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012;61:816-9.
33. CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older-Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2012;61:468-70.
34. Christie CD, Glover AM, Willke MJ, Marx ML, Reising SF, Hutchinson NM. Containment of pertussis in the regional pediatric hospital during the Greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 1995;16:556-63. http://dx.doi.org/10.2307/30141094.
35. Kurt TL, Yeager AS, Guenette S, Dunlop S. Spread of pertussis by hospital staff. JAMA 1972;221:264-7. http://dx.doi.org/10.1001/jama.1972.03200160016004.
36. Linnemann CC Jr, Perlstein PH, Ramundo N, Minton SD, Englender GS. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975;306:540-3. http://dx.doi.org/10.1016/S0140-6736(75)90907-1.
37. Valenti WM, Pincus PH, Messner MK. Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child 1980;134:520-1.
38. Calugar A, Ortega-Sánchez IR, Tiwari T, Oakes L, Jahre JA, Murphy TV. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006;42:981-8. http://dx.doi.org/10.1086/500321.
39. CDC. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011;60:1709-11.
40. CDC. Hepatitis surveillance report No. 60. Atlanta, GA: US Department of Health and Human Services, CDC; 2005.
41. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990;263:1218-22. http://dx.doi.org/10.1001/jama.1990.03440090052025.
42. Osterholm MT, Garayalde SM. Clinical viral hepatitis B among Minnesota hospital personnel. Results of a ten-year statewide survey. JAMA 1985;254:3207-12. http://dx.doi.org/10.1001/jama.1985.03360220073032.
43. CDC. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1997;46(No. RR-18).
44. Schillie S, Murphy TV, Sawyer M, et al. CDC guidance for evaluating healthcare personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep 2013;62(RR-10):1-19.
45. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchman SD; Hospital Infection Control Practices Advisory Committee. Guideline for infection control in healthcare personnel, 1998. Infect Control Hosp Epidemiol 1998;19:407-63. http://dx.doi.org/10.2307/30142429.
46. Hales CM, Harpaz R, Ortega-Sanchez I, Bialek SR. Update on recommendations for use of herpes zoster vaccine. MMWR Morb Mortal Wkly Rep 2014;63:729-31.
47. United States Government Accountability Office. Report to Congressional Committees. Medicare-many factors, including administrative challenges, affect access to Part D vaccinations. GAO-12-61. December 2011. http://www.gao.gov/products/GAO-12-61.
48. Hurley LP, Lindley MC, Harpaz R, et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med 2010;152:555-60. http://dx.doi.org/10.7326/0003-4819-152-9-201005040-00005.
49. CDC. Noninfluenza vaccination coverage among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2013;62:66-72.
50. Williams WW, Lu P-J, O'Halloran A, et al. Noninfluenza vaccination coverage among adults-United States, 2012. MMWR Morb Mortal Wkly Rep 2014;63:95-102.
51. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014;63(No. RR-5):1-30.
52. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2014. MMWR Morb Mortal Wkly Rep 2015;64:784-92. http://dx.doi.org/10.15585/mmwr.mm6429a3.
53. Elam-Evans LD, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2013. MMWR Morb Mortal Wkly Rep 2014;63:625-33.
54. Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. J Infect Dis 2011;204:566-73. http://dx.doi.org/10.1093/infdis/jir341.
55. Liu G, Markowitz LE, Hariri S, Panicker G, Unger ER. Seroprevalence of 9 human papillomavirus types in the United States, 2005-2006. J Infect Dis 2015;213:191-8.
56. Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ. Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway. J Infect Dis 2015;211:206-15. http://dx.doi.org/10.1093/infdis/jiu413.
57. Chesson HW, Markowitz LE. The cost-effectiveness of human papillomavirus vaccine catch-up programs for women. J Infect Dis 2015;211:172-4. http://dx.doi.org/10.1093/infdis/jiu414.
58. DeNavas-Walt C, Proctor BD, Smith JC. Income, poverty, and health insurance coverage in the United States: 2011. Washington, DC: US Department of Commerce, US Census Bureau; 2012. http://www.census.gov/prod/2012pubs/p60-243.pdf.
59. Sudano JJ Jr, Baker DW. Intermittent lack of health insurance coverage and use of preventive services. Am J Public Health 2003;93:130-7. http://dx.doi.org/10.2105/AJPH.93.1.130.
60. Beal AC, Doty MM, Hernandez SE, Shea KK, Davis K. Closing the divide: how medical homes promote equity in health care-results from the Commonwealth Fund 2006 Health Care Quality Survey. New York, NY: The Commonwealth Fund; 2007.
61. Lu PJ, Euler GL, Harpaz R. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. Am J Prev Med 2011;40:e1-6. http://dx.doi.org/10.1016/j.amepre.2010.10.012.
62. Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine 2009;27:882-7. http://dx.doi.org/10.1016/j.vaccine.2008.11.077.
63. CDC. Influenza vaccination among pregnant women, the 2011-12 season. MMWR Morb Mortal Wkly Rep 2012;61:758-63.
64. CDC. Influenza vaccination coverage among health-care personnel-the 2011-12 season. MMWR Morb Mortal Wkly Rep 2012;61:753-7.
65. Lu P-J, Rodriguez-Lainz A, O'Halloran A, Greby S, Williams WW. Adult vaccination disparities among foreign-born populations in the U.S., 2012. Am J Prev Med 2014;47:722-33. http://dx.doi.org/10.1016/j.amepre.2014.08.009.
66. Grieco EM, Acosta YD, de la Cruz GP, et al. The foreign born population in the United States, 2010. Washington, DC: US Department of Commerce, US. Census Bureau; 2012. http://www.census.gov/prod/2012pubs/acs-19.pdf.
67. Malone N, Baluja KF, Costanzo JM, Davis CJ. The foreign born population in the United States, 2000. Washington, DC: US Department of Commerce, US. Census Bureau; 2003. http://www.census.gov/prod/2003pubs/c2kbr-34.pdf.
68. Pew Hispanic Center. Statistical portrait of the foreign born population in the United States, 2011. Washington DC: Pew Hispanic Center; 2015. http://www.pewhispanic.org/2013/01/29/statistical-portrait-ofthe-foreign-born-population-in-the-united-states-2011.
69. Bridges CB, Coyne-Beasley T. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older-United States, 2014. MMWR Morb Mortal Wkly Rep 2014;63:110-2.
70. CDC. Global routine vaccination coverage, 2011. MMWR Morb Mortal Wkly Rep 2012;61:883-5.
71. Walker PF, Barnett ED. An introduction to the field of refugee and immigrant healthcare. In: Walker PF, Barnett ED, eds. Immigrant medicine. Philadelphia, PA: Saunders Elsevier; 2007.
72. World Health Organization. WHO recommendations for routine immunization: summary tables. Geneva, Switzerland: World Health Organization; 2015. http://www.who.int/immunization/policy/immunization_tables/en.
73. World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2014 global summary. Geneva, Switzerland: World Health Organization; 2015. http://apps.who.int/immunization_monitoring/globalsummary/schedules?sc%5Bd%5D=&sc%5BOK%5D=OK.
74. UNICEF. Immunization. New York, NY: UNICEF. http://www.unicef.org/immunization.
75. Reynolds MA, Kruszon-Moran D, Jumaan A, Schmid DS, McQuillan GM. Varicella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999-2004. Public Health Rep 2010;125:860-9.
76. Ayers JW, Juon HS, Lee S, Park E. Hepatitis B vaccination prevalence and its predictors among Asian, Pacific Islander, Native American, and multiracial adults in the National Health and Nutrition Examination Survey. J Immigr Minor Health 2010;12:847-52. http://dx.doi.org/10.1007/s10903-009-9309-9.
77. Derose KP, Escarce JJ, Lurie N. Immigrants and health care: sources of vulnerability. Health Aff (Millwood) 2007;26:1258-68. http://dx.doi.org/10.1377/hlthaff.26.5.1258.
78. Alegría M, Cao Z, McGuire TG, et al. Health insurance coverage for vulnerable populations: contrasting Asian Americans and Latinos in the United States. Inquiry 2006;43:231-54. http://dx.doi.org/10.5034/inquiryjrnl_43.3.231.
79. Lu PJ, Williams WW, Li J, et al. Human papillomavirus vaccine initiation and awareness: U.S. young men in the 2010 National Health Interview Survey. Am J Prev Med 2013;44:330-8. http://dx.doi.org/10.1016/j.amepre.2012.11.027.
80. Buelow VH, Van Hook J. Timely immunization series completion among children of immigrants. J Immigr Minor Health 2008;10:37-44. http://dx.doi.org/10.1007/s10903-007-9048-8.
81. Singleton JA, Santibanez TA, Wortley PM. Influenza and pneumococcal vaccination of adults aged > or = 65: racial/ethnic differences. Am J Prev Med 2005;29:412-20. http://dx.doi.org/10.1016/j.amepre.2005.08.012.
82. Lindley MC, Wortley PM, Winston CA, Bardenheier BH. The role of attitudes in understanding disparities in adult influenza vaccination. Am J Prev Med 2006;31:281-5. http://dx.doi.org/10.1016/j.amepre.2006.06.025.
83. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med 2004;351:575-84. http://dx.doi.org/10.1056/NEJMsa040609.
84. Gemson DH, Elinson J, Messeri P. Differences in physician prevention practice patterns for white and minority patients. J Community Health 1988;13:53-64. http://dx.doi.org/10.1007/BF01321480.
85. Schwartz KL, Neale AV, Northrup J, et al. Racial similarities in response to standardized offer of influenza vaccination. J Gen Intern Med 2006;21:346-51. http://dx.doi.org/10.1111/j.1525-1497.2006.00401.x.
86. Daniels NA, Gouveia S, Null D, Gildengorin GL, Winston CA. Acceptance of pneumococcal vaccine under standing orders by race and ethnicity. J Natl Med Assoc 2006;98:1089-94.
87. Humiston SG, Bennett NM, Long C, et al. Increasing inner-city adult influenza vaccination rates: a randomized controlled trial. Public Health Rep 2011;126(Suppl 2):39-47.
88. Lu PJ, O'Halloran A, Ding H, Williams WW, Bridges CB, Kennedy ED. National and state-specific estimates of place of influenza vaccination among adult populations-United States, 2011-12 influenza season. Vaccine 2014;32:3198-204. http://dx.doi.org/10.1016/j.vaccine.2014.04.003.
89. Goad JA, Taitel MS, Fensterheim LE, Cannon AE. Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience. Ann Fam Med 2013;11:429-36. http://dx.doi.org/10.1370/afm.1542.
90. Martin DW, Lowery NE, Brand B, Gold R, Horlick G. Immunization information systems: a decade of progress in law and policy. J Public Health Manag Pract 2015;21:296-303. http://dx.doi.org/10.1097/PHH.0000000000000040.
91. Rolnick SJ, Parker ED, Nordin JD, et al. Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors? Vaccine 2013;31:3928-35. http://dx.doi.org/10.1016/j.vaccine.2013.06.041.
92. Poland GA, Shefer AM, McCauley M, Webster PS, Whitley-Williams PN, Peter G; National Vaccine Advisory Committee, Ad Hoc Working Group for the Development of Standards for Adult Immunization Practices. Standards for adult immunization practices. Am J Prev Med 2003;25:144-50 http://dx.doi.org/10.1016/S0749-3797(03)00120-X.